News

TSR Inc (NASDAQ:TSRI) trades with a trailing P/E of 30x, which is lower than the industry average of 33.4x. While this makes TSRI appear like a great stock to buy,Read More ...
LA JOLLA, CA – November 16, 2016 – A new study led by scientists at The Scripps Research Institute (TSRI) describes an unexpected role for proteins involved with our daily “circadian” clocks in ...
LA JOLLA, CA – August 2, 2016 – A new study, led by scientists at The Scripps Research Institute (TSRI), reveals a surprising twist in immune biology. The research in animal models suggests that ...
A top brain researcher has joined Sanford Burnham Prebys Medical Discovery Institute, bringing with him groundbreaking work on the genetics of Alzheimer’s disease and a team of 25 resear… ...
Sigma-Aldrich Corporation today announced a partnership with The Scripps Research Institute to fund research and provide immediate, day-of-publication access to TSRI researchers' discoveries for ...
The new affiliation between TSRI and Calibr aspires to accelerate that timeline, as well as to increase the number of basic science discoveries that are translated into first-in-class drugs.
Now, researchers at The Scripps Research Institute (TSRI) have described a new method for adorning cells with various glycans and screening interactions between glycans and proteins.
TSRI scientists find clues to cancer drug failure Scripps Research Institute LA JOLLA, CA - March 2, 2015 - Cancer patients fear the possibility that one day their cells might start rendering many ...
AWS Mainframe Migration Comptency Partner Network TSRI achieves AWS mainframe migration competency status KIRKLAND, Wash., April 05, 2021 (GLOBE NEWSWIRE) -- The Software Revolution Inc. (TSRI ...
In a new study, scientists at The Scripps Research Institute have identified drug candidates that can boost a cell's ability to catch the "typos" in protein production that can cause a deadly ...